Skip to article
Astra

Cardiac Electrophysiology

Long QT Syndrome

A practical framework for confirming congenital long QT syndrome, excluding acquired QT prolongation, identifying concealed disease, initiating genotype-informed arrhythmic risk reduction, and escalating to sympathetic denervation or defibrillator-based protection when breakthrough events persist.

Clinical question: How should clinicians diagnose, risk-stratify, and manage suspected or confirmed congenital long QT syndrome?

Immediate decisions

Identify torsades risk and reversible QT prolongation first

Treat unstable ventricular arrhythmia and correct acquired contributors before assigning an inherited diagnosis.

In a patient with syncope, polymorphic ventricular tachycardia, aborted cardiac arrest, or marked QT prolongation, obtain a 12-lead ECG and immediately review all prescribed, over-the-counter, and administered drugs for QT-prolonging exposure. Acquired long QT may result from medications, electrolyte abnormalities, eating disorders, coronary artery disease, and bradyarrhythmia; these conditions must be addressed before interpreting QTc as evidence of congenital LQTS. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery

Document the presenting rhythm whenever possible. Torsades de pointes is a diagnostic component of the Schwartz score, but do not double-count torsades and syncope in that score because they are mutually exclusive criteria. ScienceDirectQTc Interval - an overview A history of syncope during stress carries more diagnostic weight than syncope without stress, supporting an adrenergically mediated inherited arrhythmia phenotype. ScienceDirectQTc Interval - an overview

Patients with known or suspected congenital LQTS warrant particular caution with ondansetron and other QT-prolonging agents because congenital LQTS is a recognized substrate for drug-associated torsades. annemergmedOndansetron and the Risk of Cardiac Arrhythmias If QT-prolonging therapy cannot be avoided, reassess the ECG and correct modifiable acquired factors before exposure.

Initial branch point: acquired versus inherited QT prolongation. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryScienceDirectQTc Interval - an overview
FindingInterpretationNext action
QT prolongation with QT-prolonging medication exposureAcquired long QT is possible. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryStop or substitute the culprit drug when feasible; reassess QTc after reversible factors are addressed. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
QT prolongation with electrolyte abnormality, bradyarrhythmia, eating disorder, or coronary diseaseThese are recognized acquired contributors. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryCorrect the contributor and repeat ECG assessment before concluding congenital LQTS. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
Persistent QTc prolongation without acquired cause plus stress syncope, torsades, or suggestive family historyClinical probability of congenital LQTS rises. ScienceDirectQTc Interval - an overviewCalculate Schwartz score, obtain inherited-arrhythmia evaluation, and consider genetic testing. ScienceDirectQTc Interval - an overviewScienceDirectRR Interval - an overview
Normal resting QTc but convincing personal or family historyConcealed LQTS remains possible. ScienceDirectRR Interval - an overviewPerform exercise testing with QT evaluation during prolonged recovery and consider genetic testing. ScienceDirectRR Interval - an overview

Diagnostic workup

Confirm phenotype with QTc, Schwartz scoring, and targeted provocation

Use serial, carefully measured ECG data rather than a single automated QTc result.

Obtain a high-quality resting 12-lead ECG after reversible acquired causes have been addressed. Bazett correction is commonly used: QTc equals QT divided by the square root of the RR interval. ScienceDirectQTc Interval - an overviewScienceDirectLong QT Syndrome and Perioperative Torsades de Pointes In pediatric diagnostic assessment, measure QT across multiple leads and average RR intervals over several beats; computer QT measurement is unreliable for this purpose. ScienceDirectRR Interval - an overview

Apply the Schwartz score only when ECG findings are not explained by medications or disorders that alter repolarization. QTc of at least 480 ms scores 3 points; QTc 460 to 470 ms scores 2 points; and QTc 450 ms scores 1 point. Torsades de pointes scores 2 points, T-wave alternans and notched T waves in three leads each score 1 point, and resting heart rate below the second percentile for age scores 0.5 point. ScienceDirectQTc Interval - an overview

A Schwartz score of 4 or greater indicates high probability, 2 to 3 intermediate probability, and 1 or less low probability of LQTS. ScienceDirectQTc Interval - an overview Clinical history modifies the result: stress-related syncope scores 2 points, nonstress syncope 1 point, congenital deafness 0.5 point, a family member with definite LQTS 1 point, and unexplained sudden death before age 30 years in an immediate family member 0.5 point. ScienceDirectQTc Interval - an overview

Do not dismiss a patient with a normal baseline QTc when the phenotype is compelling. Approximately 25% of patients with a pathogenic LQTS variant may have normal QTc intervals. ScienceDirectRR Interval - an overview Exercise testing or epinephrine infusion can support assessment of concealed LQTS, but neither provocative approach has adequate sensitivity or specificity to establish the diagnosis in isolation. ScienceDirectRR Interval - an overview

Schwartz diagnostic elements and probability categories. ScienceDirectQTc Interval - an overview
DomainCriterionPoints
ECGQTc ≥480 ms3 ScienceDirectQTc Interval - an overview
ECGQTc 460–470 ms2 ScienceDirectQTc Interval - an overview
ECGQTc 450 ms1 ScienceDirectQTc Interval - an overview
ECGTorsades de pointes2 ScienceDirectQTc Interval - an overview
Clinical historySyncope with stress; syncope without stress2; 1 ScienceDirectQTc Interval - an overview
Family historyDefinite LQTS in a family member; unexplained sudden death before age 30 years in an immediate relative1; 0.5 ScienceDirectQTc Interval - an overview
InterpretationLow, intermediate, and high probability≤1; 2–3; ≥4 ScienceDirectQTc Interval - an overview

Etiologic branches

Use genotype and trigger pattern to refine counseling and treatment

Genetic results inform disease classification but do not replace clinical phenotype assessment.

Prioritize the three major autosomal-dominant phenotypes—LQT1, LQT2, and LQT3—during inherited-arrhythmia assessment. LQT1 is associated with KCNQ1, LQT2 with KCNH2, and LQT3 with SCN5A; these three subtypes account for approximately 80% to 90% of LQTS cases. jaccCongenital Long QT SyndromeNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery The remainder includes less common genes, while at least 30% of clinically clear LQTS can remain genotype-elusive. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryNatureClinical utility gene card for: Long-QT syndrome

Use the clinical trigger pattern to guide evaluation of a borderline phenotype. LQT1 commonly shows marked QTc prolongation with exercise, making exercise testing with extended recovery particularly useful when baseline ECG is nondiagnostic. ScienceDirectRR Interval - an overview LQT3 is linked to SCN5A and has bradycardia-triggered arrhythmia mechanisms, so review resting rate, sleep/rest events, and bradyarrhythmia as part of phenotype assignment. jaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy

Order genetic testing in clinically probable LQTS and in selected high-suspicion concealed cases, with pre- and post-test counseling. A pathogenic variant can clarify diagnosis and permit cascade evaluation of relatives; however, a variant of uncertain significance does not independently establish disease, and a negative result does not exclude LQTS. NatureClinical utility gene card for: Long-QT syndromeScienceDirectRR Interval - an overview Evaluate relatives of affected patients because phenotype may be absent at a single assessment despite genetic predisposition. cdn clinicaltrials1 IRAS: 330619 Version 4 Date: 02/04/2024

Major LQTS branches that alter diagnostic emphasis. jaccCongenital Long QT SyndromejaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and CardiomyopathyNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryScienceDirectRR Interval - an overview
SubtypePrincipal geneUseful clinical discriminatorManagement implication
LQT1KCNQ1 NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryMarked QTc prolongation may occur with exercise. ScienceDirectRR Interval - an overviewUse exercise testing with extended recovery when baseline ECG is nondiagnostic. ScienceDirectRR Interval - an overview
LQT2KCNH2 NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryClassify using integrated ECG, symptom, family, and genetic data. jaccCongenital Long QT SyndromeNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryInstitute arrhythmic risk reduction and avoid acquired QT stressors. jacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
LQT3SCN5A NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryBradycardia-triggered arrhythmia mechanisms are described. jaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and CardiomyopathyDiscuss genotype-specific therapy, including mexiletine evidence, with an inherited-arrhythmia specialist. jaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy

Definitive management

Reduce recurrent ventricular arrhythmia risk with beta-blockade and escalation pathways

Therapy intensity should follow prior events, treatment tolerance, and breakthrough arrhythmia burden.

Initiate beta-blocker therapy for congenital LQTS as the core preventive treatment strategy; beta-blocker efficacy has been evaluated in high-risk LQT1 and LQT2 populations and is incorporated in U.S. ventricular-arrhythmia guidance. jacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society In infants and children, the paradoxical use of beta-blockers for LQTS is specifically directed at prevention of ventricular arrhythmias. neoreviews aappublicationsEvaluation and Management of Common Neonatal ... Select agent and dose through electrophysiology or inherited-arrhythmia care because the cited evidence does not provide a universal dose regimen.

Define a breakthrough cardiac event as syncope, sustained ventricular arrhythmia, aborted cardiac arrest, or other clinician-adjudicated LQTS-associated event occurring despite effective pharmacotherapy. Such events should trigger confirmation of adherence, reassessment for QT-prolonging drugs and acquired contributors, review of genotype and trigger pattern, and referral for treatment intensification. AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT SyndromeNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery

For LQT3, mexiletine has gene-specific evidence for reducing arrhythmic events in affected patients. jaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy Use this as genotype-directed management rather than empiric therapy for unclassified QT prolongation, and monitor treatment response within an inherited-arrhythmia program.

Treatment escalation for established congenital LQTS. jacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyjaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and CardiomyopathyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome
Clinical stateActionKey limitation or tradeoff
Established LQTS without documented breakthrough eventBegin and maintain beta-blocker-based arrhythmic prevention. jacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Societyneoreviews aappublicationsEvaluation and Management of Common Neonatal ...Avoid QT-prolonging drugs and acquired QT stressors; monitor symptoms and QTc. NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryannemergmedOndansetron and the Risk of Cardiac Arrhythmias
LQT3 with genotype-confirmed diseaseDiscuss mexiletine as gene-specific therapy in specialist care. jaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and CardiomyopathyDo not extrapolate genotype-directed treatment to unclassified QT prolongation. jaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
Breakthrough cardiac event on effective beta-blocker therapyReassess adherence and reversible factors; consider LCSD as treatment intensification. AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT SyndromeLCSD causes autonomic side effects and requires surgical expertise. AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and Electrophysiology
Prior aborted cardiac arrest or recurrent life-threatening arrhythmiaUrgent electrophysiology evaluation for high-risk management, including ICD consideration. jaccCongenital Long QT Syndromejacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyBalance arrhythmic protection with long-term device complications and shock burden. jacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

When to consider ICD-based protection

The 2017 AHA/ACC/HRS ventricular-arrhythmia guideline includes specific recommendations for congenital LQTS and cites long-term ICD outcome studies in high-risk LQTS. jacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Refer patients with prior aborted cardiac arrest, recurrent life-threatening arrhythmia despite medical therapy, or complex decisions regarding ICD candidacy to electrophysiology; device selection must weigh arrhythmic protection against the long-term burden of device complications and shocks. jaccCongenital Long QT Syndromejacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

When to use left cardiac sympathetic denervation

Consider left cardiac sympathetic denervation (LCSD) as treatment intensification for patients with LQTS who experience breakthrough cardiac events while receiving effective beta-blocker therapy. AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome LCSD is also used as adjunctive therapy when beta-blocker adverse effects limit dosing and dose reduction is needed. AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome

LCSD can be performed through a minimally invasive video-assisted thoracic approach, typically removing sympathetic chain/ganglia from T4 to T1 including the lower half of the left stellate ganglion. AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and Electrophysiology Discuss expected autonomic adverse effects, including unilateral hand dryness, facial color or temperature asymmetry, and abnormal sweating. AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and Electrophysiology

Longitudinal care

Screen relatives and make activity decisions through shared risk assessment

A single normal ECG does not reliably exclude familial disease.

Construct a three-generation pedigree that specifically captures definite LQTS, unexplained sudden death before age 30 years, syncope, seizures of uncertain cause, and resuscitated cardiac arrest. The Schwartz score assigns points for definite LQTS in a family member and young unexplained sudden death in an immediate relative, making family history diagnostically consequential rather than merely descriptive. ScienceDirectQTc Interval - an overview

Offer clinical and genetic evaluation to relatives when a familial pathogenic variant or convincing clinical phenotype is present. Concealed inherited arrhythmia syndromes may remain undiagnosed because phenotype can be absent at the time of assessment, and LQTS may manifest around physiologic autonomic changes such as immediately after exercise. cdn clinicaltrials1 IRAS: 330619 Version 4 Date: 02/04/2024 Repeat phenotype assessment should be guided by age, symptoms, family genotype, and inherited-arrhythmia specialist recommendations.

Do not apply blanket sports exclusion solely from the diagnostic label. Return-to-play decisions for athletes with LQTS require individualized assessment within national and international guidance, integrating clinical events, treatment adherence, QT phenotype, genotype, sport setting, and emergency-action planning. jaccReturn-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death

Follow-up decisions in familial or suspected concealed LQTS. jaccReturn-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden DeathScienceDirectQTc Interval - an overviewScienceDirectRR Interval - an overviewcdn clinicaltrials1 IRAS: 330619 Version 4 Date: 02/04/2024
ScenarioInterpretationNext step
Relative has normal resting QTc but a familial LQTS variant or strong pedigreeNormal QTc does not exclude inherited LQTS. ScienceDirectRR Interval - an overviewcdn clinicaltrials1 IRAS: 330619 Version 4 Date: 02/04/2024Arrange inherited-arrhythmia assessment, genetic counseling, and phenotype-directed testing. ScienceDirectRR Interval - an overviewcdn clinicaltrials1 IRAS: 330619 Version 4 Date: 02/04/2024
Borderline QTc with stress syncope or young sudden death in familySchwartz scoring may move the patient into intermediate or high probability. ScienceDirectQTc Interval - an overviewCalculate score, exclude acquired causes, and pursue specialized evaluation. ScienceDirectQTc Interval - an overviewScienceDirectRR Interval - an overview
Athlete with confirmed or suspected LQTSParticipation is an individualized decision rather than a label-based automatic exclusion. jaccReturn-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden DeathUse shared decision-making with inherited-arrhythmia and sports cardiology input. jaccReturn-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death

References

  1. Congenital Long QT Syndromewww.jacc.org · www.jacc.org
  2. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Societywww.jacc.org · www.jacc.org
  3. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathywww.jacc.org · www.jacc.org
  4. Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Deathwww.jacc.org · www.jacc.org
  5. Left Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and Electrophysiologywww.ahajournals.org · www.ahajournals.org
  6. Left Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndromewww.ahajournals.org · www.ahajournals.org
  7. Ion channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discoverywww.nature.com · www.nature.com
  8. The long QT syndrome family of cardiac ion channelopathieswww.nature.com · www.nature.com
  9. Clinical utility gene card for: Long-QT syndromewww.nature.com · www.nature.com
  10. Clinical utility gene card for: Long-QT Syndrome (types 1–13)www.nature.com · www.nature.com
  11. Perinatal Management of Andersen–Tawil Syndrome Using a ...obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
  12. QTc Interval - an overviewwww.sciencedirect.com · www.sciencedirect.com
  13. Long QT Syndrome and Perioperative Torsades de Pointeswww.sciencedirect.com · www.sciencedirect.com
  14. Improving long QT syndrome diagnosis by a polynomial- ...www.sciencedirect.com · www.sciencedirect.com
  15. RR Interval - an overviewwww.sciencedirect.com · www.sciencedirect.com
  16. Long QT Syndrome : New England Journal of Medicinejournals.lww.com · journals.lww.com
  17. Clinical Characteristics and Genetic Background of ...journals.lww.com · journals.lww.com
  18. Targeted next generation sequencing revealed a novel deletion- ...journals.lww.com · journals.lww.com
  19. Heart Rate and Rhythm Disorders | Pediatrics In Reviewpedsinreview.aappublications.org · pedsinreview.aappublications.org
  20. 1 IRAS: 330619 Version 4 Date: 02/04/2024cdn.clinicaltrials.gov · cdn.clinicaltrials.gov
  21. A Review of Long QT Syndrome: Everything a Hospitalist ...hosppeds.aappublications.org · hosppeds.aappublications.org
  22. Sudden Death in the Young: Information for the Primary ...pediatrics.aappublications.org · pediatrics.aappublications.org
  23. Ondansetron and the Risk of Cardiac Arrhythmiaswww.annemergmed.com · www.annemergmed.com
  24. Evaluation and Management of Common Neonatal ...neoreviews.aappublications.org · neoreviews.aappublications.org